
    
      There is a focus on interventional therapies, mechanical circulatory support and new
      cardiovascular therapeutics in patients with cardiogenic shock (CS). The investigators will
      describe current practice in study sites including concomitant patients with CS. Therefore,
      the investigators will monitor drug therapies initiated, devices being utilized as well as
      outcome and side effect of possible interventions
    
  